2-取代硫醚-5-脱氢松香基-1,3,4-恶二唑/噻二唑类化合物的合成及生物活性

以脱氢松香酸为原料,经酯化、肼解、关环和亲核取代反应得到了2-取代硫醚-5-脱氢松香基-1,3,4-恶二唑和2-取代硫醚-5-脱氢松香基-1,3,4-噻二唑类化合物。通过IR、MS、1H NMR和元素分析对产物进行了表征。初步生物活性检测结果表明,所有目标化合物都表现出一定的除草活性。     

Synthesis and biological activities of benzothiazole derivatives bearing a 1,3,4-thiadiazole moiety

A series of benzothiazole derivatives bearing a 1,3,4-thiadiazole moiety were designed, synthesized and evaluated for their antibacterial, antifungal and antiviral activities. The bioassay results indicated that most of target compounds showed good antiviral activities against tobacco mosaic virus (TMV) and antibacterial activities against Xanthomonas oryzae pv. oryzae (Xoo) and Ralstonia solanacearum (Rs). Especially, the anti-Xoo effect of title compounds 5k (N-(5-methoxybenzo[d]thiazol-2-yl)-2-((5-(2-tolyl)-1,3,4-thiadiazol-2-yl)thio)acetamide) and the anti-Rs effect of title compounds 5a (N-(5-nitrobenzo[d]thiazol-2-yl)-2-((5-(4-(trifluorom ethyl)phenyl)-1,3,4-thiadiazol-2-yl)thio)acetmide) respectively reached 52.4% and 71.6% at 100?µg/mL, which are superior to that of bismerthiazol (32.0% and 52.3%). In addition, the protective and inactivation activities of title compound 5i (N-(5-methoxybenzo [d]thiazol-2-yl)-2-((5-(4-nitrophenyl)-1,3,4-thiadiazol-2-yl)thio)acetamide) against TMV were 79.5% and 88.3%, respectively, which are better than that of ningnanmycin (76.4% and 86.8%). The above research showed that benzothiazole derivatives bearing a 1,3,4-thiadiazole moiety may be used as potential molecular templates in searching for highly-efficient antiviral and antibacterial agents.     

Novel 1,3,4-thiadiazole conjugates derived from protocatechuic acid: Synthesis,antioxidant activity,and computational and electrochemical studies

A series of 15 novel 1,3,4-thiadiazole amide derivatives containing a protocatechuic acid moiety were synthesized and structurally characterized. In addition, the corresponding imino (4) and amino (5) analogues of a phenyl-substituted 1,3,4-thiadiazole amide derivative 3a were prepared to compare the effects of the structural changes on the radical-scavenging activity. The obtained compounds were examined for their antioxidative potential by 2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) assays. In addition, selected compounds were studied by density functional theory (DFT) and cyclic voltammetry experiments. The tested compounds showed high potential to scavenging DPPH radical and ABTS radical cation compared with the referent antioxidants ascorbic acid and nordihydroguaiaretic acid (NDGA). On the basis of the calculated thermodynamic parameters, it can be concluded that the sequential proton loss electron transfer (SPLET) mechanism represents the most probable reaction path in a polar solvent for DPPH radical–scavenging activity. On the other hand, the single electron transfer followed by proton transfer (SET-PT) can be a likely mechanistic pathway in the case of an ABTS radical cation.     

Synthesis and antitumor activity of novel pyridazinone derivatives containing 1,3,4-thiadiazole moiety

Abstract

A series of novel pyridazinone derivatives containing the 1,3,4-thiadiazole moiety were synthesized and characterized by ¹H NMR, 13C NMR, spectroscopies HRMS and IR. Among them, the structure of compound 5c (2-(Tert-butyl)?4-chloro-5-((5-((2-ethylphenyl)amino)?1,3,4-thiadiazol-2-yl)thio)pyridazin-3(2H)-One) was unambiguously confirmed via single crystal X-ray diffraction analysis. The inhibitory activity of all the target compounds against MGC-803 and Bcap-37 was determined by MTT assay, with doxorubicin (the inhibition rates were 95.5?±?0.4% and 95.7?±?1.0% respectively) as a control. The preliminary results showed that the inhibitory activity of compound 5n (2-(Tert-butyl)?4-chloro-5-((5-((3-fluorophenyl)amino)?1,3,4-thiadiazol-2-yl)thio)pyridazin-3(2H)-One) was superior to the others. The inhibition rates of MGC-803 and Bcap-37 cells were 86.3?±?2.2% and 92.3?±?0.6% at a concentration of 10?μmol/L, respectively. The preliminary structure-activity relationship showed that when the 2-position of the benzene ring was substituted by a methyl group, such as compound 5j (2-(Tert-butyl)?4-chloro-5-((5-((2,3-dimethylphenyl)amino)?1,3,4-thiadiazol-2-yl)thio)pyridazin-3(2H)-One), it exhibited good anticancer activity on MGC-803 cells. Besides, introducing fluorine, chlorine, or trifluoromethyl group onto the benzene ring, such as compound 5?m (2-(Tert-butyl)?4-chloro-5-((5-((4-(trifluoromethoxy)phenyl)amino)?1,3,4-thiadiazol-2-yl)thio)pyridazin-3(2H)-One), displayed good anticancer activity on MGC-803 and Bcap-37 cells.     

Synthesis and characterization of a Cu(II) complex of 2-benzylmercapto-5-methyl-1,3,4-thiadiazole (C10H10N2S2)

A Cu(II) complex of 2-benzylmercapto-5-methyl-1,3,4-thiadiazole was synthesized and characterized. The crystal structure of the copper complex and the free ligand were determined by single-crystal X-ray diffraction at room temperature: {[Cu(C₁₀H₁₀N₂S₂)₂(Cl)₂], P 1 triclinic, a = 8.1450(2) Å, b = 8.1690(2) Å, c = 10.8180(3) Å, α = 97.4040(12)°, β = 101.6270(11)°, γ = 116.1431(14)°; C₁₀H₁₀N₂S₂ ligand, Pbca orthorhombic, a = 8.7938(7) Å, b = 9.6491(7) Å, c = 25.3552(18) Å}. The metal complex framework consists of discrete units that provide crystalline stability through a network of van der Waals contacts. The Cu(II) is coordinated by two chloride ions and two 2-benzylmercapto-5-methyl-1,3,4-thiadiazole monodentate ligands showing a distorted square planar configuration. Both thiadiazole ligands coordinate through the N atom bonded to the benzylthio substituted C atom.

The FTIR spectroscopic data are consistent with this structural model. Analysis of the magnetic susceptibility from 5 K to room temperature indicates the presence of paramagnetic Cu(II), confirmed by the EPR spectrum.     

Preparation and characterization of Co(II), Ni(II) and Cu(II) complexes of a ligand containing 1,3,4-thiadiazole groups

(1R,2R)-1,2-bis-(5-amino-1,3,4-thiadiazole-2-yl)ethane-1,2-diol (L) has been prepared by the reaction of thiosemicarbazide with (2R,3R)-(+)-tartaric acid (I) and phosphorous oxychloride, and its complexes with Co(II), Ni(II) and Cu(II) have been obtained. The structures of the ligand and its complexes have been established by i. r., ¹H- and ¹³C-n.m.r. spectra, u.v.–vis–nir spectroscopy, elemental analyses, T.g.-D.t.a. and magnetic susceptibility measurements.     

Synthesis,characterization and biological studies of Co(II), Ni(II), Cu(II) and Zn(II) complexes with pyrral-l-histidinate

The Schiff base ligand, pyrral-l-histidinate(L) and its Co(II), Ni(II), Cu(II) and Zn(II) complexes were synthesized and characterized by elemental analysis, mass, molar conductance, IR, electronic, magnetic measurements, EPR, redox properties, thermal studies, XRD and SEM. Conductance measurements indicate that the above complexes are 1:1 electrolytes. IR data show that the ligand is tridentate and the binding sites are azomethine nitrogen, imidazole nitrogen and carboxylato oxygen atoms. Electronic spectral and magnetic measurements indicate tetrahedral geometry for Co(II) and octahedral geometry for Ni(II) and Cu(II) complexes, respectively. The observed anisotropic g values indicate the presence of Cu(II) in a tetragonally distorted octahedral environment. The redox properties of the ligand and its complexes have been investigated by cyclic voltammetry. Thermal decomposition profiles are consistent with the proposed formulations. The powder XRD and SEM studies show that all the complexes are nanocrystalline. The in vitro biological screening effects of the synthesized compounds were tested against the bacterial species, Escherichia coli, Bacillus subtilis, Pseudomonas aeruginosa and Staphylococcus aureus; fungal species, Aspergillus niger, Aspergillus flavus and Candida albicans by the disc diffusion method. The results indicate that complexes exhibit more activity than the ligand. The nuclease activity of the ligand and its complexes were assayed on CT DNA using gel electrophoresis in the presence and absence of H₂O₂.     

Synthesis,spectral characterization,electrochemical and biological studies of Co(II), Ni(II) and Cu(II) complexes with thiocarbohydrazone

A series of metal complexes of Co(II), Ni(II) and Cu(II) have been synthesized with the Schiff base derived from thiocarbohydrazide and 8-formyl-7-hydroxy-4-methylcoumarin. The structures of the complexes have been proposed by elemental analyses, molar conductance, spectral (IR, UV-Vis, ESR and FAB-mass), magnetic, thermal and electrochemical studies. These complexes are soluble in DMF and DMSO and molar conductance values indicate that they are non-electrolytes. Elemental analyses of the complexes confirm stoichiometry ML ·; 2H₂O [M=Co(II), Ni(II) and Cu(II)]. Spectroscopic studies indicate coordination occurs through phenolic oxygen after deprotonation and nitrogen of azomethine. The Schiff base and its complexes have also been screened for antibacterial (Escherichia coli, Streptococcus aureus, Streptococcus pyogenes and Pseudomonas aeruginosa) and antifungal activities (Aspergillus niger, Aspergillus flavus and cladosporium) by the MIC method. The brine shrimp bioassay was also carried out to study their in vitro cytotoxic properties.     

1,2,3—噻二唑衍生物的合成及其生物活性

自1976年Arndt等合成植物生长调节剂噻苯隆[1]似来，有关含1，2，3一噻二唑化0合物的生物活性的研究就不断有报道[2～5]．为了寻找新的具有较好生物活性的化合物，本文以5-氨基-1，2，3-噻二唑为中间体合成了5种不同取代基的磺酰脲类化合物、3种SChiff碱类化合物及吡唑类、酰亚胺类化合物各1种，共10种新化合物．其反应式如下：1实验部分MT－3型元素分析仪；Schimadzu-IR-435型红外光谱仪，KBr压片；Jeolfx－90Q型或BrukerAC－P200型核磁共振仪（CDCI。，DMSO－de，TMS）；VGZAB－HS型质谱仪；Yanaco熔点仪（温度计未经校正）…     

Dodecanoyl thiosemicarbazide derivatives as useful synthons in the synthesis of 1,2,4-triazole, 1,3,4-thiadiazole,and 1,3-benzothiazole derivatives

A convenient synthesis of the dodecanoyl thiosemicarbazide derivatives 3a, b has been achieved from the reaction of 2-benzamido-3-arylacryloylhydrazides 1a, b and lauroyl isothiocyanate (2). The thiosemicarbazide derivative 3a is used as precursor for synthesis of 1,2,4-triazole, 1,3,4-thiadiazole, and 1,3-benzothiazole derivatives. The antimicrobial activity of some of the synthesized compounds was tested.     

Synthesis and characterization of 1,3,4,-thiadiazole-containing polyethers from 2,5-bis (4-fluorophenyl)-1,3,4-thiadiazole and various aromatic diols

Seven 1,3,4-thiadiazole-containing polyethers with reduced viscosities of 0.27–1.44 dL/g were synthesized by the high-temperature solution polycondensation of novel activated difluoride, 2,5-bis (4-fluorophenyl)-1,3,4-thiadiazole, with aromatic diols possessing a variety of ring structures. The expected chemical structures were confirmed by IR and ¹H-NMR spectroscopy and elemental analysis. Of all the polymers, three polyethers were highly crystalline and soluble only in limited solvents such as concentrated sulfuric acid. The other polyethers were amorphous and dissolved easily in a variety of organic solvents including N-methyl-2-pyrrolidone (NMP), phenols, and chlorinated hydrocarbons. Colorless to slightly yellow-colored, transparent, and tough films could be cast from the NMP solutions of the amorphous polyethers. The mechanical properties of the films were excellent, and their tensile strength, elongation at break, and tensile moduli were in the ranges of 48–72 MPa, 5–7%, and 1.3–1.9 GPa, respectively. The amorphous polyethers had high glass transition temperatures of 204–299°C. All the polyethers were highly thermally and thermooxidatively stable and exhibited no weight loss up to 400°C, with 10% weight loss being recorded at 464–513°C in air. © 1994 John Wiley & Sons, Inc.     

Ni(II) and Co(III) complexes of 5-methyl-1,3,4-thiadiazole-2-thiol: syntheses,spectral, structural,thermal analysis,and DFT calculation

Two new complexes, [Ni(en)₂(mtt)₂] (1) and [Co(en)₂(mtt)₂](mtt) (2) (Hmtt = 5-methyl-1,3,4-thiadiazole-2-thiol and en = ethylenediamine), have been synthesized and characterized by various physicochemical techniques. Complexes 1 and 2 crystallize in monoclinic and orthorhombic system with space groups P 21/n and P 21 21 21, respectively. The molecular structures of 1 and 2 show that the metal ions are six-coordinate bonded through four equatorial nitrogens of two en and two axial nitrogens of mtt ligands. The crystal structures of the complexes reveal that mtt is present in thione form and bound to the metal ion through the thiadiazole nitrogen. The crystal structures of the complexes are stabilized by various intermolecular hydrogen bonding providing supramolecular architecture. Complex 2 is also stabilized by weak π···π interactions occurring between two thiadiazole rings. The bioefficacies of the ligand and complexes have been examined against the growth of bacteria to evaluate their antimicrobial potential. The biological results suggest that 2 is more active than the ligand and 1 against the tested bacteria. The geometries of the ligand and the complexes have been optimized by the DFT method and the results are compared with the X-ray diffraction data. The Co(III) complex exhibits an irreversible Co(III)/Co(II) process while the Ni(II) complex displays quasi-reversible Ni(II)/Ni(III) redox processes with large peak separation as compared to that expected for a one electron process which is thought to be coupled with some chemical reaction.     

Docking studies to evaluate the biological activities of the Co(II) and Ni(II) complexes containing the triazine unit: supported by structural,spectral, and theoretical studies

Abstract

Two complexes of 5,6-di(2-furyl)-3-(2-pyridyl)-1,2,4-triazine (L), [Co(L)₂(NO₃)₂] (1), and [Ni(L)₂(NO₃)₂] (2), were prepared and identified along with L by elemental analysis, FT-IR, UV-Vis, and ¹H NMR spectroscopies and single-crystal X-ray diffraction. All coordination modes of the 1,2,4-triazine unit and also of the nitrato ligand in coordination with cobalt and nickel atoms were studied by analysis of the Cambridge Structural Database (CSD) to compare with the new results. X-ray structure analysis of complexes 1 and 2 revealed that the metal atom in both complexes has an octahedral geometry with MN₄O₂ environment (M: Co (1), Ni (2)). The ligand acts as a bidentate N^tzN^py-donor and forms a five-membered planar chelate ring. In addition to the hydrogen bonds, the crystal network is stabilized by π–π stacking interactions between pyridine rings of the ligands of adjacent complexes. The thermodynamic stability of the two conformational isomers of the 5,6-di(2-furyl)-3-(2-pyridyl)-1,2,4-triazine and their charge distribution patterns were studied by DFT and NBO analysis, respectively. The ability of the uncoordinated ligand conformers and complexes 1 and 2 to interact with nine selected biomacromolecules (BRAF kinase, CatB, DNA gyrase, HDAC7, rHA, RNR, TrxR, TS, and Top II) was investigated by docking calculations and compared with that of doxorubicin. Also an analog of the ligand in which the furyl rings are replaced by phenyl groups is included in these studies.     

新型2-胺基-1,3,4-噻二唑类化合物的合成及其抗肿瘤活性的研究

设计合成了一系列新型的N1-(5-取代基-1,3,4-噻二唑-2-基)-N3-取代苯基-脲类化合物,并测定了它们的抗肿瘤活性.标题化合物对肿瘤转移的生物活性实验是以荷Lewis肺癌小鼠为模型的.生物活性表明部分标题化合物对肿瘤的转移和肿瘤生长具有较好的抑制作用.其结构经元素分析、红外光谱及1H NMR确证.     

Synthesis,characterization and biological properties of Co(II), Ni(II), Cu(II) and Zn(II) complexes with an SNO functionalized ligand

Some new metal(II) complexes, ML₂[M = Co, Ni, Cu and Zn], of 2-acetylthiophene benzoylhydrazone ligand (HL) containing a trifunctional SNO-donor system have been synthesized and characterized on the basis of physicochemical data by elemental analysis, magnetic moment, molar conductance, thermogravimetric and spectroscopic (electronic, IR, ¹H NMR and ¹³C NMR) data. The ligand functions as monobasic SNO tridentates where the deprotonated enolic form is preferred in the coordination producing distorted octahedral complexes.     

2-取代硫醚-5-(3,4,5-三甲氧基苯基)-1,3,4-噻二唑类化合物的合成、结构与体外抗癌活性

以天然产物没食子酸为原料经醚化、酯化、酰肼化、成盐、闭环、硫醚化六步反应合成了6个2-取代硫醚-5-(3,4,5-三甲氧基苯基)-1,3,4-噻二唑类衍生物, 釆用铟催化下水相合成目标化合物8, 具有反应条件温和, 合成收率高的特点; 用IR, ¹H NMR, ¹³C NMR和元素分析对各化合物进行了表征及结构确证, 并用X射线单晶衍射法测定了化合物8a [2-(2-氯-5-吡啶甲基)硫醚-5-(3,4,5-三甲氧基苯基)-1,3,4-噻二唑]的晶体结构, 采用MTT法进行了新化合物抑制PC3和BGC-823癌细胞体外试验, 结果表明在5μmol•L^－1浓度下化合物8e对PC3的抑制活性为55.71%. 化合物8b对BGC-823细胞抑制活性为66.21%.     

Synthesis of 4,5-Dihydro-1,3,4-thiadiazole-2-carboxamide and 2-Carbamoyl-4,5-dihydro-1,3,4-thiadiazole 1-Oxide Derivatives Based on Hydrazones of Oxamic Acid Thiohydrazides

We have developed a method for obtaining derivatives of 4,5-dihydro-1,3,4-thiadiazole-2-carboxamide by acylation of hydrazones of oxamic acid thiohydrazides. Oxidation of the dihydrothiadiazole ring of the indicated products by hydrogen peroxide leads to formation of 2-carbamoyl-4,5-dihydro-1,3,4-thiadiazole 1-oxides.     

Chemoselective one-pot synthesis of 2-phenylamino-5-alkylthio-1,3,4-thiadiazole derivatives from phenylthiosemicarbazide and CS2

A novel and fairly efficient chemoselective one-pot method has been developed for the synthesis of both 2-phenylamino-5-alkylthio-1,3,4-thiadiazole and bis-(2-phenylamino-5-alkylthio-)1,3,4-thiadiazole derivatives from phenylthiosemicarbazide and CS₂.